Publications
Mar 21, 2025
Publications
Predicting tuberculosis drug efficacy in preclinical and clinical models from in vitro data
Janice J N Goh, Anu Patel, Bernard Ngara, Rob C van Wijk, Natasha Strydom, Qianwen Wang, Nhi Van, Tracy M Washington, Eric L Nuermberger, Bree B Aldridge, et al
iScience. 2025 Jan 30;28(3):111932
Mar 24, 2025
Publications
Large-scale combination screens reveal small-molecule sensitization of antibiotic-resistant gram-negative ESKAPE pathogens
Megan W Tse, Meilin Zhu, Benjamin Peters, Efrat Hamami, Julie Chen, Kathleen P Davis, Samuel Nitz, Juliane Weller, Thulasi Warrier, Diana K Hunt, Yoelkys Morales, Tomohiko Kawate Jeffrey L Gaulin, Jon H Come, Juan Hernandez-Bird, Wenwen Huo, Isabelle Neisewander, Xiao Yu, Jose A Aceves-Salvador, Laura L Kiessling, Deborah T Hung, Joan Mecsas, Bree B Aldridge, Ralph R Isberg #, Paul C Blainey # (#=equal contribution)
Proc Natl Acad Sci U S A. 2025 Apr;122(13):e2402017122. doi: Epub 2025 Mar 24.
Apr 14, 2025
Publications
Using AlphaFold-Multimer to study novel protein-protein interactions of predation essential hypothetical proteins in Bdellovibrio
Ibukun John Abulude, Isabel Cristina Rodríguez Luna, Alejandro Sánchez Varela, Andrew Camilli, Daniel E Kadouri, Xianwu Guo
Front Bioinform. 2025 Apr 14:5:1566486
May 22, 2025
Publications
Cholesterol metabolism and intrabacterial potassium homeostasis are intrinsically related in Mycobacterium tuberculosis
Yue Chen, Berge Hagopian, Shumin Tan
PLoS Pathog. 2025 May 22;21(5):e1013207.
May 27, 2025
Publications
Differentiating Peromyscus leucopus bone marrow-derived macrophages for characterization of responses to Borrelia burgdorferi and lipopolysaccharide
Christopher C Wells, Tanja Petnicki-Ocwieja, Shumin Tan, Stephen C Bunnell, Sam R Telford 3rd, Linden T Hu, Jeffrey S Bourgeois
Infect Immun. 2025 May 27:e0058124
Sep 22, 2025
Publications
Preclinical in vivo evaluation of a gonococcal multivalent vaccine containing antigens identified by CASS
Front Immunol. 2025 Sep 22:16:1688536.
Aug 7, 2025
Publications
Race and ethnicity and the risk of community-acquired third-generation cephalosporin-resistant uropathogens: a systematic review and meta-analysis
Antimicrob Steward Healthc Epidemiol. 2025 Aug 7;5(1):e172.
Sep 23, 2025
Publications
Management of human babesiosis – approaches and perspectives
Edouard Vannier, Klaus-Peter Hunfeld, Robert P. Smith & Peter J. Krause
Expert Rev Anti Infect Ther..2025 Sep;23(9):739-752. Epub 2025 Jul 5.
Sep 25, 2025
Publications
Fighting AntimicroBial Resistance in Carceral Settings (FABRICS) study on antibiotics prescribing in New England prisons
Antimicrobial Stewardship & Healthcare Epidemiology, Cambridge University Press; September 25, 2025, 5, e235, 1–4
Dec 16, 2025
Publications
Inter-organizational Relations and Policy Coordination The Quadripartite and Antimicrobial Resistance
Global Governance: A Review of Multilateralism and International Organizations, 31(4), 428-473.
DOI: 10.1163/19426720-03104001
Mar 1, 2025
Publications
Language and racial disparities in treatment initiation for patients with pulmonary non-tuberculous mycobacteria
Disparities in testing and treatment of pulmonary nontuberculous mycobacteria (P-NTM) warrant further investigation into language and race’s impact on treatment initiation. The objective of the study is to compare the length of treatment initiation for P-NTM patients assessed in the pulmonary and infectious diseases clinics through language and race.
Sep 22, 2025
Publications
Caution against using plasma mNGS for NHSN CLABSI surveillance
We read with interest the recent expansion of the National Healthcare Safety Network (NHSN) surveillance criteria to include non-culture-based testing (NCT), including plasma metagenomic next-generation sequencing (mNGS), in bloodstream infection (BSI) definitions. 1 While mNGS provides diagnostic utility in complex cases, Reference MacIntyre, Hirst, Duttagupta, Hollemon, Hong and Blauwkamp2 we have concerns about its integration into healthcare-associated infection (HAI) surveillance frameworks such as NHSN, where standardization, reproducibility, and clinical relevance are essential.